Understanding how brain cells interact in hereditary spastic paraplegias
Uncover the role of glia-neuron crosstalk in hereditary spastic paraplegias
This study is looking at how certain brain cells interact with nerve cells in people with hereditary spastic paraplegias (HSP), a condition that causes muscle weakness and stiffness, to see if changes in fat processing by these brain cells might be harming the nerve cells, with the hope of finding new ways to help treat HSP.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10845380 on NIH RePORTER |
What this research studies
This research investigates the interactions between glial cells and neurons in hereditary spastic paraplegias (HSP), a group of genetic disorders that lead to muscle weakness and spasticity. The study aims to explore how lipid metabolism, regulated by glial cells, may contribute to the degeneration of motor neurons in HSP. Using co-cultures of neurons and glial cells derived from patients, researchers will examine the underlying mechanisms of these interactions and their impact on neuronal health. The findings could provide insights into potential therapeutic targets for treating HSP.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hereditary spastic paraplegia, particularly those with the SPG3A form caused by ATL-1 gene mutations.
Not a fit: Patients with hereditary spastic paraplegia who do not have the SPG3A mutation or those with other unrelated neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve muscle function and quality of life for patients with hereditary spastic paraplegias.
How similar studies have performed: Previous research has shown promising results in understanding glial cell functions in neurodegenerative diseases, suggesting that this approach may yield valuable insights.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Li, Xue-Jun — University of Illinois at Chicago
- Study coordinator: Li, Xue-Jun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.